Introduction
============

COPD is characterized by progressive airflow limitation and is associated with abnormal inflammatory response of the airways and lungs, caused by inhalation of noxious gases and particles, such as those contained in tobacco smoke.[@b1-copd-12-849] Besides inducing lung damage, COPD presents multisystemic manifestations and can be associated with comorbidities which greatly affect prognosis.[@b1-copd-12-849] The association between these factors can determine structural and functional changes in the respiratory and peripheral skeletal muscles which directly affect cardiac autonomic modulation, possibly increasing risk of mortality in these patients.[@b2-copd-12-849],[@b3-copd-12-849]

The cardiovascular system functioning and the mechanisms regulating the autonomic adjustments have been investigated, both in basal and physical effort conditions by the analysis of heart rate variability (HRV),[@b3-copd-12-849] which represents a powerful research tool capable of identifying increased risk of mortality[@b4-copd-12-849]--[@b8-copd-12-849] and poor prognosis[@b8-copd-12-849] in these patients. COPD patients present attenuated response of the HRV index and previous studies have shown increased sympathetic activity, during lower limb aerobic and resistance exercise.[@b2-copd-12-849],[@b9-copd-12-849]--[@b11-copd-12-849] In addition, these HRV attenuated responses seem to be related to respiratory muscle weakness.[@b12-copd-12-849] Other studies, however, showed that impaired responses during exercise in these patients may be partially explained by bronchoconstriction, hypoxemia, hypercapnia, and systemic inflammation.[@b9-copd-12-849],[@b13-copd-12-849]--[@b16-copd-12-849]

Isometric contraction (IC) and the Valsalva maneuver (VM) are widely used autonomic tests to assess altered autonomic responses in different populations.[@b11-copd-12-849],[@b17-copd-12-849] Physiologically, IC causes a marked increase in systolic blood pressure (SBP) and heart rate (HR), due to inhibition of vagal modulation on the sinus node,[@b11-copd-12-849],[@b17-copd-12-849] which is dependent on the percentage of maximum voluntary contraction. As for the VM, it determines marked hemodynamic changes, with accentuated cardiovascular overload.[@b18-copd-12-849],[@b19-copd-12-849] However, the studies which investigated the cardiac autonomic responses to these maneuvers in COPD patients are scarce. Stewart et al[@b20-copd-12-849] observed the HR responses to the handgrip test and the VM and they concluded that 18% of COPD patients had attenuated autonomic responses consistent with autonomic neuropathy and these were associated with hypoxemia.[@b20-copd-12-849] However, in their study, the patients' cardiac autonomic function was not evaluated by means of HRV analysis.[@b20-copd-12-849] It is noteworthy that such maneuvers provide indices which represent powerful predictors of cardiovascular impairment and reliable diagnostic and prognostic markers.[@b21-copd-12-849]--[@b23-copd-12-849]

Therefore, the aim of the present study was to evaluate the HRV indices and HR responses during IC and VM in COPD patients. We hypothesized that the severity of COPD would negatively impact on the autonomic responses during IC and VM.

Methods
=======

Study design
------------

We performed a cross-sectional and randomized cross-over study within Santa Cruz Hospital's Pulmonary Rehabilitation Program (Santa Cruz do Sul, RS, Brazil). All patients were formally invited to participate in the study by the responsible researcher. The study was approved by the Research Ethics Committee of the University of Santa Cruz do Sul, protocol number 128943, and all volunteers signed an informed consent statement prior to participation.

Subjects
--------

After acceptance of the patients, 30 patients with a clinical diagnosis of COPD from a physician; forced expiratory volume in 1 second (FEV~1~)/forced vital capacity (FVC) ratio \<0.7 and FEV~1~ \<60% of predicted, with good cognitive function and without disease exacerbation during the previous 15 days were included in the study. Patients with musculoskeletal disorders or neurological conditions affecting the locomotor system in such a way that would preclude participation in the protocol, a clinical diagnosis of lung cancer, current alcoholism, complex cardiac arrhythmias, uncontrolled metabolic disease such as diabetes, thyroid changes and systemic arterial hypertension (with or without the use of beta-blockers) or electrocardiogram alterations were excluded from the study (n=8) ([Figure 1](#f1-copd-12-849){ref-type="fig"}).

Measurements
------------

Patients were evaluated in a laboratory at a temperature of 22°C and relative humidity between 50% and 60%. They were instructed to avoid stimulants and alcoholic drinks and not to perform exhausting physical exercise the day before the test; they were also instructed not to smoke or use bronchodilators for 6 hours before the test. Patients underwent a clinical evaluation to record: sex, age, body mass index, smoking history and COPD staging. Afterward, vital signs (SBP, diastolic blood pressure \[DBP\], respiratory frequency \[RF\], peripheral oxygen saturation \[SpO~2~\]) were measured and the dominant upper limb perceived exertion was estimated using the Borg scale.

In addition, familiarization procedures were performed with the equipment and experimental protocols so that patients could learn how to correctly perform the dominant upper limb IC and the VM before the actual testing. The HRV signal was recorded at rest (5 minutes), during upper limb IC (2 minutes) and during the VM (15 seconds), the order of which was determined by simple randomization by envelope, and during recovery (5 minutes) ([Figure 1](#f1-copd-12-849){ref-type="fig"}).

### Pulmonary function

The pulmonary function was assessed using a digital spirometer (Microloop^®^, MK8, Care Fusion, Hoechberg, Germany), which provided measures of the FVC, the FEV~1~, and the FEV~1~/FVC ratio. Spirometry was performed according to the recommendations of the American Thoracic Society[@b24-copd-12-849] and the results were analyzed according to the values predicted by Pereira et al.[@b25-copd-12-849] The classification of severity of airflow limitation in COPD was performed according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) recommendations and patients were classified as moderate (GOLD II), severe (GOLD III), or very severe (GOLD IV).[@b1-copd-12-849]

### Respiratory muscle strength (RMS)

The RMS was assessed using a digital manometer (MDI^®^, MVD300, Porto Alegre, Brazil), which provided measures of the maximum inspiratory pressure (MIP) and the maximum expiratory pressure (MEP). The assessment was performed according to the recommendations for the Brazilian population. MIP and MEP were obtained from residual volume and total lung capacity; during the maneuver, the subjects remained seated, wearing nose clips and with a rigid, plastic flanged mouthpiece in place.[@b26-copd-12-849] The values were then compared with those described in literature and expressed as percentage of predicted values.[@b26-copd-12-849] The inspiratory muscle weakness was determined by an MIP \<60 cmH~2~O.[@b27-copd-12-849]

### Hand-grip strength (HGS) and IC load determination

The HGS was determined during dominant upper limb IC, using a hand dynamometer (Jamar^®^, Bolingbrook, IL, USA); three maximum contractions were performed and their average was computed.[@b28-copd-12-849] The IC load was determined as 30% of the HGS. The load should be sustained for 2 minutes, preceded by 5 minutes of rest and followed by 5 minutes of recovery. Patients performed dominant upper limb IC while sitting, with shoulder abducted, elbow flexed to 90º, forearm in neutral pronation--supination and wrist extended between 0° and 30°.[@b29-copd-12-849]

### VM

The VM was performed with patients in sitting position. After a deep inspiration their nose was occluded by a nose clip to prevent air leakage. The patients performed a breath-holding maneuver for 15 seconds,[@b30-copd-12-849] after which expiration was initiated on the researcher's command. Facial flushing, jugular stasis, chest movements and rapid HR increase followed by bradycardia were observed to guarantee the correct performance of the VM.[@b30-copd-12-849] The test was preceded by 5 minutes of rest and followed by 5 minutes of recovery.

### HRV

HR and RR intervals (iR-R) were recorded using a telemetric cardiac monitor (Polar^®^ S810i, Kempele, Finland). An elastic band (Polar T31 transmitter) was placed around the patient's thorax at the level of the lower third of the sternum, while the patient was in a sitting position; signals were continuously transmitted to the receiving unit by electromagnetic field. Recorded data were then transferred to Kubios HRV^®^ analysis software (version 2.2, Finland) for subsequent analysis.

The signal processing was carried out as follows: at rest (5 minutes), during upper limb IC (90 seconds; the first 30 seconds of the signal were discarded in order to obtain a stable signal portion), and post-exercise recovery (5 minutes). The HRV signal collected during upper limb IC was analyzed in the time domain (the analysis provided mean RR interval \[mean RR\], RR interval standard deviation \[STD RR\], mean HR, STD HR, square root of the mean squared differences of successive RR intervals \[RMSSD\] and the HRV triangular index \[RR tri index\]) and in the frequency domain (the analysis provided the HRV signal power in the low frequency \[LF\], indicating sympathetic activity, in the high frequency \[HF\], indicating parasympathetic activity, and the LF/HF ratio).

As for the VM, the iR-R were analyzed during rest, at the peak of the VM, after cessation of the VM (when the lowest HR value is referred to as nadir), and during recovery. The Valsalva index (VI) was calculated as the ratio between the longest iR-R during recovery and the shortest iR-R during the peak of the VM. The VI is used as an indirect measure of the autonomic nervous system (ANS) integrity, characterized by values above 1.4.[@b31-copd-12-849]

Statistical analysis
--------------------

Sample size calculation was performed a priori using Gpower software according to the variable RMSSD; to achieve a statistical power of 80% (β=0.20), with α=0.05, it was calculated that a minimum of 20 patients were needed.[@b11-copd-12-849] Data were analyzed using the Sigmaplot^®^ statistical package (version 11.0, Systat Software Inc., San Jose, CA, USA). Data were tested for normality through the Shapiro--Wilk test and presented descriptively as mean and STD (parametric) or as median and minimum and maximum interval (non-parametric). An analysis of variance (ANOVA) analysis for multiple comparisons with Tukey's post hoc test was performed. A Pearson correlation analysis was performed to investigate the correlations between variables. A linear regression model was used to determine the effect of the clinical variables on the HRV parameters. Residuals were evaluated under the assumptions of normality, constant variance, and independence. *P*\<0.05 was considered significant.

Results
=======

Clinical characteristics of the patients included in the study are shown in [Table 1](#t1-copd-12-849){ref-type="table"}. We observed a prevalence of patients of male sex, with obesity, and with severe COPD in stage III and IV (77%). Despite the higher frequency of patients with severe disease, the changes in inspiratory muscle strength were also distributed among the patients studied (50% MIP normal values and 50% inspiratory muscle weakness).

[Table 2](#t2-copd-12-849){ref-type="table"} shows that the upper limb IC significantly increased the SBP (*P*=0.002), the DBP (*P*=0.020), the RF (*P*=0.007), and the upper limb perceived exertion (*P*\<0.001); as for the time domain index, mean HR increased (*P*=0.001), while RMSSD and RR tri index decreased (*P*=0.005 and *P*=0.005, respectively), suggesting an HR increase and a vagal activity and total HRV decrease. As for the frequency domain index, the LF power increased (*P*=0.033) and the HF power decreased (*P*=0.002), indicating a sympathetic modulation increase and a vagal modulation decrease.

Moderate to strong correlations were found between inspiratory muscle strength, airway obstruction and lung capacity, and the HRV parameters during upper limb IC ([Figure 2](#f2-copd-12-849){ref-type="fig"}), demonstrating the influence and importance of airflow obstruction and inspiratory muscle weakness over the parasympathetic modulation and HR behavior.

We could observe that the lung function indices (FEV~1~ and FVC) directly influenced cardiac autonomic modulation during upper limb IC. This result was confirmed by a multiple linear regression, which showed that airway obstruction and lung capacity justified 30% of mean HR during upper limb IC ([Table 3](#t3-copd-12-849){ref-type="table"}).

The HR behavior during the VM is shown in [Figure 3](#f3-copd-12-849){ref-type="fig"}. The HR behavior at rest, during and at the peak of the VM, after cessation of the VM (nadir) and during recovery indicates that the COPD patients included in this study presented an HR response pattern similar to that observed in previous, similar studies performed on other populations.[@b19-copd-12-849],[@b30-copd-12-849] The VI value (=0.7) indicates an integrity loss of the ANS in these patients.

The HR values during the VM are represented in [Figure 4](#f4-copd-12-849){ref-type="fig"}. We could observe a significant HR increase during the VM, with a recovery to baseline values after cessation of the maneuver. The nadir suggests an adequate bradycardic response to the maneuver.

The correlations between FEV~1~/FVC with rest-HR and VM-HR underscored the direct influence of airway obstruction on cardiac performance in COPD patients ([Figure 5](#f5-copd-12-849){ref-type="fig"}).

Discussion
==========

The main findings of the present study can be summarized as follows: 1) COPD patients responded properly to the upper limb IC and to the VM; however, 2) HR recovery from the VM appeared to be impaired; 3) the severity of the disease, quantified by FEV~1~ and FVC, as well as MIP, were associated with increased parasympathetic modulation; 4) chronotropic responses were associated with bronchoconstriction.

As expected, during upper limb IC, patients presented increased HR, increased sympathetic activation and reduced total HRV; we observed that all indices went back to their normal values during recovery. A previous study showed that 18% of COPD patients presented attenuated autonomic responses, consistent with autonomic neuropathy and associated with hypoxemia.[@b20-copd-12-849] However, in that study, the authors did not evaluate cardiac autonomic modulation by computing robust HRV indices, but only by analyzing HR responses,[@b20-copd-12-849] different to our study, in which linear and nonlinear HRV indices, widely accepted as important tools to determine cardiac autonomic changes, were studied.[@b32-copd-12-849],[@b33-copd-12-849]

We observed an association between airway obstruction and inspiratory muscle weakness ([Figure 2](#f2-copd-12-849){ref-type="fig"}). These findings were previously reported by other authors in different autonomic tests, as postural change, and during dynamic exercise.[@b2-copd-12-849],[@b3-copd-12-849],[@b12-copd-12-849],[@b13-copd-12-849] It has been reported that increased cardiac parasympathetic modulation in COPD patients was directly associated with increased airway obstruction.[@b15-copd-12-849] This response may be associated with changes in both lung compliance and lung stretch reflex responses in patients with cardiopulmonary disease.[@b13-copd-12-849]

A particularly relevant finding of our study is the association between HR chronotropic response during IC and the severity of the disease. These results may be explained by augmented muscle metaboreflex activation that could occur in those patients at a more severe stage of COPD.[@b22-copd-12-849] This mechanism, associated with systemic inflammation present in COPD, may contribute to augmented sympathetic responses to exercise.[@b16-copd-12-849] Our results confirm the importance of applying the IC maneuver, which has been widely used for risk assessment in cardiovascular disease patients, as a powerful tool to assess the severity of the disease in this population.[@b22-copd-12-849]

It has been reported that, in cardiac patients and in healthy young people, HR increases at the beginning of the IC, due to increased muscle tension; this phenomenon may be attributed to vagal withdrawal on the sinus node.[@b11-copd-12-849],[@b17-copd-12-849],[@b34-copd-12-849],[@b35-copd-12-849] The mechanisms responsible for these responses after muscle fiber activation may have a central role in the activation of central neural circuits and in the determination of cardiovascular adjustments.[@b34-copd-12-849]--[@b36-copd-12-849] In the present study, we observed expected HR responses in COPD patients.

However, the respiratory muscle weakness, suggested by MIP reduction, seems to be associated with cardiac autonomic control impairment.[@b12-copd-12-849] Moreover, air trapping and subsequent FEV~1~ reduction, present in severe COPD patients, as well as accentuated bronchoconstriction, have been shown to be associated with vagal tone attenuation and with cardiac autonomic control alteration.[@b12-copd-12-849],[@b13-copd-12-849] Therefore, it could be supposed in our study that impaired RMS and reduced FEV~1~ and FVC could deeply influence the HRV behavior, both at rest and during isometric exercise.

Interestingly, in our study, during the VM, COPD patients presented an expected HR response; however, the HR values could not be fully recovered 5 minutes after cessation of the maneuver. These aspects are particularly relevant since it is well known that the recovery of the HR response represents a powerful prognostic marker for cardiovascular disease.[@b19-copd-12-849] The HR response to the VM is mainly influenced by cardiac autonomic control, which is responsible for the rapid increase phase, with vagal withdrawal over the sinus node, as well as for the reduction after cessation of the VM, with vagal tone activation. These adjustments may occur in response to the activation of cardiopulmonary receptors and arterial baroreceptors.[@b17-copd-12-849],[@b19-copd-12-849],[@b37-copd-12-849],[@b38-copd-12-849]

The present study is relevant as it highlights the direct influence of the airway obstruction on the HR parameters ([Figure 5](#f5-copd-12-849){ref-type="fig"}). The interaction between sympathetic reflex and vagal reflex, probably triggered by the pulmonary stretch receptors, is responsible for the cardiovascular responses during the VM.[@b17-copd-12-849],[@b19-copd-12-849],[@b37-copd-12-849] The peripheral vascular resistance, which increases in response to decreased venous return, caused by increased intrathoracic pressure during the VM, drops immediately after cessation of the maneuver; this promotes an increase in venous return which, through the baroreceptors, stimulates vagal recovery, leading to marked bradycardia.[@b30-copd-12-849],[@b37-copd-12-849] Taking into account the structural and mechanical pathophysiological changes in the respiratory system of COPD patients, the results reported in literature justify a VI lower than 0.7, confirming an ANS integrity loss in these subjects.

This study has limitations that should be addressed. Given our strict exclusion criteria, and the difficulty in triaging patients with a 95% rate of sinus rhythm, our sample may not be representative for the entire COPD population, as many patients present various types of arrhythmias that compromise the recording and analysis of signals. In accordance with our main objective, we chose to perform a randomized cross-sectional study to minimize inter-individual variability, where the patient represented his or her own control, which justified the absence of a control group.

This study is of great significance for the clinical management of COPD patients; our results about upper limb IC, about the influence of inspiratory muscle weakness and lung function, and about these patients' responses to the VM, can contribute to the development of novel diagnostic tools; moreover, they may be used to develop modern tools for the evaluation, in the clinical setting, of the effects of pulmonary rehabilitation interventions, such as respiratory muscle training and static and dynamic resistance training.

Conclusion
==========

The COPD patients included in this study responded appropriately to the upper limb IC, with an HR increase, a sympathetic modulation increase, and a parasympathetic modulation decrease. However, the recovery of the HR after the VM was impaired and the VI presented a value below normal range. The severity of the disease and MIP were associated with increased parasympathetic modulation. Finally, higher chronotropic response was associated to bronchoconstriction in these patients.

The main findings of the present study can be summarized as follows: COPD patients responded properly to the upper limb IC and to the VM; HR recovery after VM appeared to be impaired; the severity of the disease was associated with increased parasympathetic modulation; chronotropic responses were associated to bronchoconstriction.
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![Flowchart -- sampling and study phases.\
**Notes:** 5′: 5 minutes; 2′: 2 minutes; 15″: 15 seconds.\
**Abbreviations:** n, number of patients; IC, isometric contraction; VM, Valsalva maneuver.](copd-12-849Fig1){#f1-copd-12-849}

![Relationship between respiratory muscle strength and lung function, and heart rate variability index during upper limb isometric contraction.\
**Notes:** (**A**) Negative correlation between RMSSD (ms) and FEV~1~ (L/s); (**B**) negative correlation between mean HR (1/min) and FEV~1~ (L/s); (**C**) negative correlation between RMSSD (ms) and FVC (L/s); (**D**) positive correlation between HF (nu) and MIP (cmH~2~O). The Pearson correlation analysis was performed. Significance level: *P*≤0.05.\
**Abbreviations:** RMSSD, square root of the mean squared differences of successive RR intervals; FEV~1~, forced expiratory volume in 1 second; mean HR, mean heart rate; FVC, forced vital capacity; HF, high frequency; nu, normalized units; MIP, maximum inspiratory pressure; cmH~2~O, centimeters of water.](copd-12-849Fig2){#f2-copd-12-849}

![Response of HR during the VM in COPD patients.\
**Notes:** (**A**) Beat-to-beat HR response during the VM of one patient. a, rest; b, peak of the VM; c, Nadir value and d, recovery. COPD patients presented an expected HR response pattern, with an increase during the VM, followed by bradycardia after cessation of the VM, and with a final increase during recovery. (**B**) VI of the COPD patients. The mean VI value (=0.75±0.0) indicates an ANS integrity loss in these patients.\
**Abbreviations:** ANS, autonomic nervous system; HR, heart rate; VM, Valsalva maneuver; VI, Valsalva index.](copd-12-849Fig3){#f3-copd-12-849}

![HR values during the VM.\
**Notes:** ANOVA with Tukey's post hoc analysis was performed. Significance level: *P*\<0.05.\
**Abbreviations:** HR, heart rate; VM, Valsalva maneuver; ANOVA, analysis of variance.](copd-12-849Fig4){#f4-copd-12-849}

![Relationship between lung function and HR values during the VM in COPD patients.\
**Notes:** (**A**) Negative correlation between FEV~1~/FVC (% predicted) and HR; (**B**) negative correlation between FEV~1~/FVC (% predicted) and HR during the VM. Significance level: *P*\<0.05. The Pearson correlation analysis was performed.\
**Abbreviations:** HR, heart rate; VM, Valsalva maneuver; FEV~1~, forced expiratory volume in 1 second; FVC, forced vital capacity.](copd-12-849Fig5){#f5-copd-12-849}

###### 

COPD patients' clinical characteristics

  Variables                     COPD (n=22)
  ----------------------------- -------------
  Age (years)                   63.5±7.3
  Sex, male, n (%)              15 (68.2)
  BMI (kg/m^2^)                 26.0±5.2
  BMI classification            
   Underweight, n (%)           5 (22.7)
   Eutrophic, n (%)             7 (31.8)
   Obese, n (%)                 10 (45.5)
  Pulmonary volumes             
   FEV~1~ (L/s)                 1.0±0.6
   FEV~1~ (% predicted)         38.0±19.5
   FVC (L/s)                    1.9±0.5
   FVC (% predicted)            56.2±16.5
   FEV~1~/FVC                   0.5±0.1
   FEV~1~/FVC (% predicted)     65.3±21.3
  Staging (GOLD)                
   Stage II, n (%)              5 (22.7)
   Stage III, n (%)             10 (45.5)
   Stage IV, n (%)              7 (31.8)
  Respiratory muscle strength   
   MIP (cmH~2~O)                −68.0±29.9
   MIP (% predicted)            72.9±33.9
   MEP (cmH~2~O)                99.2±38.3
   MEP (% predicted)            98.6±33.3
  Hand-grip strength            
   Dominant (kgf)               30.3±11.1
   30% (sustained)              9.0±3.4
  MIP \<60 cmH~2~O, n (%)       
   Yes                          11 (50.0)
   No                           11 (50.0)

**Note:** Data presented as mean ± standard deviation unless stated otherwise.

**Abbreviations:** n (%), number of patients (% of sample size); BMI, body mass index; FEV~1~, forced expiratory volume in 1 second; FVC, forced vital capacity; GOLD, Global Initiative for Chronic Obstructive Lung Disease; MIP, maximum inspiratory pressure; MEP, maximum expiratory pressure.

###### 

Clinical and HRV parameters at rest, during IC and during recovery

  Variables         COPD n=22                                                                          
  ----------------- ------------------- -------------------------------------------------------------- --------------------------------------------------------------------------------------------------------
  SBP (mmHg)        109.5±11.8          124.0±15.8[\*](#tfn4-copd-12-849){ref-type="table-fn"}         117.6±10.4
  DBP (mmHg)        70.2±7.7            73.9±7.1[\*](#tfn4-copd-12-849){ref-type="table-fn"}           67.8±6.7[α](#tfn5-copd-12-849){ref-type="table-fn"}
  RF (rpm)          18.6±2.9            21.6±2.9[\*](#tfn4-copd-12-849){ref-type="table-fn"}           19.8±3.0
  BORG -- upper     6.0 (6.0--6.0)      13.0 (9.2--14.0)[\*](#tfn4-copd-12-849){ref-type="table-fn"}   8.0 (6.2--9.0)[α](#tfn5-copd-12-849){ref-type="table-fn"},[\#](#tfn6-copd-12-849){ref-type="table-fn"}
  limb                                                                                                 
  SpO~2~ (%)        93.1±2.2            93.4±1.7                                                       94.0±1.9
  Mean RR (ms)      720.9±120.5         717.5±87.2                                                     715.4±86.7
  STD RR (ms)       17.6±9.0            12.8±7.4                                                       18.4±7.3
  Mean HR (1/min)   79.4±13.4           86.9±12.0[\*](#tfn4-copd-12-849){ref-type="table-fn"}          80.1±13.9
  STD HR (1/min)    2.0 (1.7--2.3)      1.5 (1.0--1.9)[\*](#tfn4-copd-12-849){ref-type="table-fn"}     2.2 (1.5--2.9)
  RMSSD (ms)        17.0 (10.0--29.9)   12.4 (9.2--15.7)[\*](#tfn4-copd-12-849){ref-type="table-fn"}   17.6 (11.3--22.0)[α](#tfn5-copd-12-849){ref-type="table-fn"}
  RR tri index      4.4 (2.8--6.2)      3.7 (2.2--4.5)[\*](#tfn4-copd-12-849){ref-type="table-fn"}     4.8 (3.3--6.5)[α](#tfn5-copd-12-849){ref-type="table-fn"}
  HF (nu)           41.7±20.5           35.5±14.8[\*](#tfn4-copd-12-849){ref-type="table-fn"}          45.3±23.3[α](#tfn5-copd-12-849){ref-type="table-fn"}
  LF (nu)           53.3±21.8           61.0±19.6[\*](#tfn4-copd-12-849){ref-type="table-fn"}          48.3±23.2[α](#tfn5-copd-12-849){ref-type="table-fn"}
  LF/HF             1.3 (0.6--4.2)      1.4 (1.1--2.7)[\*](#tfn4-copd-12-849){ref-type="table-fn"}     0.9 (0.2--1.4)[α](#tfn5-copd-12-849){ref-type="table-fn"}

**Notes:** Data are presented as mean ± standard deviation or as median and interquartile range. ANOVA with Tukey's post hoc analysis was performed:

(*P*\<0.05) for IC vs rest;

(*P*\<0.05) for recovery vs IC;

(*P*\<0.05) for recovery vs rest.

**Abbreviations:** HRV, heart rate variability; IC, isometric contraction; SBP, systolic blood pressure; DBP, diastolic blood pressure; RF, respiratory frequency; SpO~2~, peripheral oxygen saturation; mean RR, mean RR interval; STD RR, RR interval standard deviation; mean HR, mean heart rate; STD HR, heart rate standard deviation; RMSSD, square root of the mean squared differences of successive RR intervals; RR tri index, HRV triangular index; LF, low frequency; HF, high frequency; nu, normalized units; LF/HF, ratio between LF power and HF power; ANOVA, analysis of variance.

###### 

Results of multiple linear regression to determine the influence of FEV~1~ and FVC on mean HR during upper limb isometric contraction

  Variables   β coefficient   *P*-value
  ----------- --------------- -----------
  Constant    64.58           \<0.001
  FEV~1~      −18.92          0.018
  FVC         21.64           0.014

**Notes:** Adjusted *R*^2^=0.298; *F*=3.67 (*P*=0.045). Equation to predict mean HR during isometric contraction: 64.58 + (21.64× FVC) -- (18.92× FEV~1~).

**Abbreviations:** FEV~1~, forced expiratory volume in 1 second; mean HR, mean heart rate; FVC, forced vital capacity.
